Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Oncogenes, Fusion Genes and Tumor Suppressor Genes

Overexpression of survivin initiates hematologic malignancies in vivo

Abstract

Survivin is an inhibitor of apoptosis protein family member that has an essential role in cellular proliferation as a component of the chromosome passenger complex. Survivin is highly expressed in embryos and in proliferating adult tissues, but it is not expressed in most differentiated cells. During tumorigenesis, however, survivin expression is dramatically upregulated. Although many studies have shown that survivin is required for cancer cells, the extent to which survivin contributes to the initiation of tumors is unknown. Here we show that transgenic mice that overexpress survivin in hematopoietic cells are at an increased risk of hematologic tumors. In examining how survivin might contribute to tumorigenesis, we observed that hematopoietic cells engineered to overexpress survivin are less susceptible to apoptosis. We conclude that survivin may promote tumorigenesis by imparting a survival advantage to cells that acquire additional genetic lesions.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Fukuda S, Pelus LM . Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther 2006; 5: 1087–1098.

    Article  CAS  Google Scholar 

  2. Adida C, Haioun C, Gaulard P, Lepage E, Morel P, Briere J et al. Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood 2000; 96: 1921–1925.

    CAS  PubMed  Google Scholar 

  3. Cong XL, Han ZC . Survivin and leukemia. Int J Hematol 2004; 80: 232–238.

    Article  CAS  Google Scholar 

  4. Schlette EJ, Medeiros LJ, Goy A, Lai R, Rassidakis GZ . Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma. J Clin Oncol 2004; 22: 1682–1688.

    Article  CAS  Google Scholar 

  5. Lopes R, Castro I, Pontes P, Candeias J, Lemoine NR, Sambade C . Expression profile of survivin in acute leukaemias: the importance of differential splicing. Leukemia 2005; 19: 1284–1286.

    Article  CAS  Google Scholar 

  6. Fangusaro JR, Caldas H, Jiang Y, Altura RA . Survivin: an inhibitor of apoptosis in pediatric cancer. Pediatr Blood Cancer 2006; 47: 4–13.

    Article  Google Scholar 

  7. Romagnoli M, Trichet V, David C, Clement M, Moreau P, Bataille R et al. Significant impact of survivin on myeloma cell growth. Leukemia 2007; 21: 1070–1078.

    Article  CAS  Google Scholar 

  8. Altieri DC . Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 2008; 8: 61–70.

    Article  CAS  Google Scholar 

  9. Okada H, Mak TW . Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer 2004; 4: 592–603.

    Article  CAS  Google Scholar 

  10. Uren AG, Wong L, Pakusch M, Fowler KJ, Burrows FJ, Vaux DL et al. Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr Biol 2000; 10: 1319–1328.

    Article  CAS  Google Scholar 

  11. Ruchaud S, Carmena M, Earnshaw WC . The chromosomal passenger complex: one for all and all for one. Cell 2007; 131: 230–231.

    Article  CAS  Google Scholar 

  12. Lu CD, Altieri DC, Tanigawa N . Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 1998; 58: 1808–1812.

    CAS  PubMed  Google Scholar 

  13. Fukuda S, Pelus LM . Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis. Blood 2001; 98: 2091–2100.

    Article  CAS  Google Scholar 

  14. Xing Z, Conway EM, Kang C, Winoto A . Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis. J Exp Med 2004; 199: 69–80.

    Article  CAS  Google Scholar 

  15. Okada H, Bakal C, Shahinian A, Elia A, Wakeham A, Suh WK et al. Survivin loss in thymocytes triggers p53-mediated growth arrest and p53-independent cell death. J Exp Med 2004; 199: 399–410.

    Article  CAS  Google Scholar 

  16. Altznauer F, Martinelli S, Yousefi S, Thurig C, Schmid I, Conway EM et al. Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils. J Exp Med 2004; 199: 1343–1354.

    Article  CAS  Google Scholar 

  17. Leung CG, Xu Y, Mularski B, Liu H, Gurbuxani S, Crispino JD . Requirements for survivin in terminal differentiation of erythroid cells and maintenance of hematopoietic stem and progenitor cells. J Exp Med 2007; 204: 1603–1611.

    Article  CAS  Google Scholar 

  18. Ma AC, Chung MI, Liang R, Leung AY . The role of survivin2 in primitive hematopoiesis during zebrafish development. Leukemia 2009; 23: 712–720.

    Article  CAS  Google Scholar 

  19. Fukuda S, Singh P, Moh A, Abe M, Conway EM, Boswell HS et al. Survivin mediates aberrant hematopoietic progenitor cell proliferation and acute leukemia in mice induced by internal tandem duplication of Flt3. Blood 2009; 114: 394–403.

    Article  CAS  Google Scholar 

  20. McCrann DJ, Yezefski T, Nguyen HG, Papadantonakis N, Liu H, Wen Q et al. Survivin overexpression alone does not alter megakaryocyte ploidy nor interfere with erythroid/megakaryocytic lineage development in transgenic mice. Blood 2008; 111: 4092–4095.

    Article  CAS  Google Scholar 

  21. Kirsammer G, Jilani S, Liu H, Davis E, Gurbuxani S, Le Beau MM et al. Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome. Blood 2008; 111: 767–775.

    Article  CAS  Google Scholar 

  22. Huang Z, Dore LC, Li Z, Orkin SH, Feng G, Lin S et al. GATA-2 reinforces megakaryocyte development in the absence of GATA-1. Mol Cell Biol 2009; 29: 5168–5180.

    Article  CAS  Google Scholar 

  23. Visvader JE, Fujiwara Y, Orkin SH . Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Dev 1998; 12: 473–479.

    Article  CAS  Google Scholar 

  24. Jasinski M, Keller P, Fujiwara Y, Orkin SH, Bessler M . GATA1-Cre mediates Piga gene inactivation in the erythroid/megakaryocytic lineage and leads to circulating red cells with a partial deficiency in glycosyl phosphatidylinositol-linked proteins (paroxysmal nocturnal hemoglobinuria type II cells). Blood 2001; 98: 2248–2255.

    Article  CAS  Google Scholar 

  25. Hock H, Meade E, Medeiros S, Schindler JW, Valk PJ, Fujiwara Y et al. Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival. Genes Dev 2004; 18: 2336–2341.

    Article  CAS  Google Scholar 

  26. Altieri DC . Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 2003; 22: 8581–8589.

    Article  CAS  Google Scholar 

  27. Fulda S . Inhibitor of apoptosis proteins in hematological malignancies. Leukemia 2009; 23: 467–476.

    Article  CAS  Google Scholar 

  28. Guha M, Altieri DC . Survivin as a global target of intrinsic tumor suppression networks. Cell Cycle 2009; 8: 2708–2710.

    Article  CAS  Google Scholar 

  29. Grossman D, Kim PJ, Blanc-Brude OP, Brash DE, Tognin S, Marchisio PC et al. Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53. J Clin Invest 2001; 108: 991–999.

    Article  CAS  Google Scholar 

  30. Allen SM, Florell SR, Hanks AN, Alexander A, Diedrich MJ, Altieri DC et al. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression. Cancer Res 2003; 63: 567–572.

    CAS  PubMed  Google Scholar 

  31. Nguyen HG, Makitalo M, Yang D, Chinnappan D, St Hilaire C, Ravid K . Deregulated Aurora-B induced tetraploidy promotes tumorigenesis. FASEB J 2009; 23: 2741–2748.

    Article  CAS  Google Scholar 

  32. Nguyen HG, Ravid K . Tetraploidy/aneuploidy and stem cells in cancer promotion: The role of chromosome passenger proteins. J Cell Physiol 2005; 208: 12–22.

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank Todd Yezefski for initiating these studies and Hui Liu and Jeremy Wen for assistance with animal colony maintenance. This work was supported, in part, by a Grant from the NIH (DK074693). JDC is a Scholar of the Leukemia and Lymphoma Society.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J D Crispino.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Small, S., Keerthivasan, G., Huang, Z. et al. Overexpression of survivin initiates hematologic malignancies in vivo. Leukemia 24, 1920–1926 (2010). https://doi.org/10.1038/leu.2010.198

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2010.198

Keywords

This article is cited by

Search

Quick links